نمایش مختصر رکورد

dc.contributor.authorAskari, Nahiden_US
dc.contributor.authorjafari, Elhamen_US
dc.contributor.authorBagheri-Hosseinabadi, Zahraen_US
dc.contributor.authorAmiri, Maryamen_US
dc.contributor.authorKhanamani Falahati-pour, Sakinehen_US
dc.contributor.authorBaghery, Fatemehen_US
dc.contributor.authorDini, Alien_US
dc.contributor.authorMirzaei, Vahiden_US
dc.contributor.authorKhanamani Falahati-pour, Soudehen_US
dc.date.accessioned1404-02-11T06:54:18Zfa_IR
dc.date.accessioned2025-05-01T06:54:19Z
dc.date.available1404-02-11T06:54:18Zfa_IR
dc.date.available2025-05-01T06:54:19Z
dc.date.issued2024-12-01en_US
dc.date.issued1403-09-11fa_IR
dc.date.submitted2023-11-25en_US
dc.date.submitted1402-09-04fa_IR
dc.identifier.citationAskari, Nahid, jafari, Elham, Bagheri-Hosseinabadi, Zahra, Amiri, Maryam, Khanamani Falahati-pour, Sakineh, Baghery, Fatemeh, Dini, Ali, Mirzaei, Vahid, Khanamani Falahati-pour, Soudeh. (2024). Amelioration of Diabetes and Nonalcoholic Fatty Liver Disease by Pistachio Kernel Protein Hydrolysate in Rats. Journal of Medicinal plants and By-product, 13(4), 1129-1136. doi: 10.22034/jmpb.2024.364228.1630en_US
dc.identifier.issn2322-1399
dc.identifier.issn2588-3739
dc.identifier.urihttps://dx.doi.org/10.22034/jmpb.2024.364228.1630
dc.identifier.urihttps://jmpb.areeo.ac.ir/article_131082.html
dc.identifier.urihttps://iranjournals.nlai.ir/handle/123456789/1159302
dc.description.abstractDiabetes Mellitus (DM) and Nonalcoholic Fatty Liver Disease (NAFLD) are prevalent conditions that affect the metabolism and can lead to liver injury. They are often associated with obesity and insulin resistance. Protein Hydrolysate of Pistachio Kernel (PHPK) is a natural product obtained from pistachio proteins by enzymatic hydrolysis. It has been reported to have antioxidant, anti-inflammatory, and antidiabetic properties. We investigated the hepatoprotective effects of PHPK in rats with type 1 DM or NAFLD induced by a high-sugar diet. We used 96 male Wistar rats and divided them into four groups: Control, NAFLD, Diabetic, and PHPK-treated (5, 50, 500 mg/kg). We fed the rats with different diets for 8 weeks and then administered PHPK orally for 4 weeks. We collected blood and liver samples for biochemical and histopathological analysis. We found that DM and NAFLD increased the levels of liver enzymes, cholesterol, and triglycerides in the blood and caused hepatic damage, as shown by distorted liver architecture, necrotic hepatocytes, sinusoidal dilatation, and kupffer cell proliferation. PHPK administration reduced the severity of these alterations and improved the liver function and morphology in rats with DM and NAFLD. Our results suggest that PHPK has beneficial effects on DM and NAFLD, indicating its potential as a natural remedy for these disorders. Future research is needed to identify the specific compound(s) responsible for its antidiabetic effects and to elucidate its mechanism of action.en_US
dc.format.extent892
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoen_US
dc.publisherIranian Medicinal Plants Societyen_US
dc.relation.ispartofJournal of Medicinal plants and By-producten_US
dc.relation.isversionofhttps://dx.doi.org/10.22034/jmpb.2024.364228.1630
dc.subjectDiabetes mellitusen_US
dc.subjectNon-Alcoholic Fatty Liver Diseaseen_US
dc.subjectBioactive peptideen_US
dc.subjectPistaciaen_US
dc.subjectBiochemistryen_US
dc.titleAmelioration of Diabetes and Nonalcoholic Fatty Liver Disease by Pistachio Kernel Protein Hydrolysate in Ratsen_US
dc.typeTexten_US
dc.typeResearch Paperen_US
dc.contributor.departmentDepartment of Biotechnology, Institute of Sciences and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iranen_US
dc.contributor.departmentPathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iranen_US
dc.contributor.departmentDepartment of Clinical Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iranen_US
dc.contributor.departmentDepartment of Medical Laboratory Science, Faculty of Paramedical Science, Jiroft University of Medical Sciences, Jiroft, Iranen_US
dc.contributor.departmentDepartment of Pharmacology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iranen_US
dc.contributor.departmentPistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iranen_US
dc.contributor.departmentPistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iranen_US
dc.contributor.departmentClinical Research Development Unit, Ali-Ibn Abi-Talib Hospital, Rafsanjan University of Medical Sciences, Rafsanjan, Iranen_US
dc.contributor.departmentPistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iranen_US
dc.citation.volume13
dc.citation.issue4
dc.citation.spage1129
dc.citation.epage1136


فایل‌های این مورد

Thumbnail

این مورد در مجموعه‌های زیر وجود دارد:

نمایش مختصر رکورد